FOCUSING on IMPROVING THE LIVES of PATIENTS
WITH DIFFICULT-TO-TREAT DISEASES
RECENT NEWS
BioMed Valley Discoveries’ ulixertinib (BVD-523) receives Fast Track designation and launches Phase II trial. See details here.
July 28, 2020
COMBINING the EXPERTISE of our TEAM and our PARTNERS to BREAK THROUGH BARRIERS in EARLY STAGE DRUG DEVELOPMENT